Endogenous modulation of monoamine oxidase in schizophrenic and normal humans
Abstract
Plasma from normal subjects and chronic schizophrenic patients produced nearly equal inhibitory effects on platelet and bovine brain monoamine oxidase (MAO) activity. Plasma from controls and patients with high platelet MAO activity caused less decrease in platelet MAO kinetic variables (Km, Vmax) than plasma from subjects with midrange or low MAO activity. When bovine striatal MAO was used, with serotonin as substrate, plasma from schizophrenic patients caused less decrease in Vmax than plasma from controls. These inhibitory effects are associated with the presence in plasma of one or more nonalbumin proteins with low molecular weight.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).